Characterization of the platelet transcriptome by RNA sequencing in patients with acute myocardial infarction

Platelets

Volumn 27, Issue 3, 2016, Pages 230-239

  Eicher, John D ^a,b   Wakabayashi, Yoshiyuki ^b   Vitseva, Olga ^c   Esa, Nada ^d   Yang, Yanqin ^b   Zhu, Jun ^b   Freedman, Jane E ^d   McManus, David D ^d   Johnson, Andrew D ^a,b  

^a FRAMINGHAM HEART STUDY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Gene expression; Myocardial infarction; Platelet aggregation; RNA seq

Indexed keywords

ACTIN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; COLLAGEN; GLUCOSE TRANSPORTER 3; POTASSIUM CHANNEL KCNE1; RNA; TRANSCRIPTION FACTOR ERG; TRANSCRIPTOME;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ATP6V1G2 GENE; AURKB GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHDC3 GENE; FBXL4 GENE; FEMALE; FKBP5 GENE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; ITGA2 GENE; MALE; MIAT GENE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OST4 GENE; PDGFB GENE; PDGFC GENE; PPBP GENE; PRIORITY JOURNAL; PVRL3 GENE; PZP GENE; RNA SEQUENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ST3GAL6 GENE; TAOK2 GENE; THROMBOCYTE; THROMBOCYTE AGGREGATION; TRANSCRIPTION REGULATION; BLOOD; BLOOD CLOTTING PARAMETERS; ELECTROCARDIOGRAPHY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTOR; SEQUENCE ANALYSIS; THROMBOCYTE ACTIVATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD PLATELETS; ELECTROCARDIOGRAPHY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; RISK FACTORS; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME;

EID: 84941670799     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2015.1083543     Document Type: Article

References (60)

1. Rowley JW, Schwertz H, Weyrich AS. Platelet mRNA: The meaning behind the message. Curr Opin Hematol 2012; 19 (5): 385-391
2. Italiano Jr JE, Shivdasani RA. Megakaryocytes and beyond: The birth of platelets. J Thromb Haemost 2003; 1 (6): 1174-1182
3. Bugert P, Dugrillon A, Gunaydin A, Eichler H, Kluter H. Messenger RNA profiling of human platelets by microarray hybridization. Thromb Haemost 2003; 90 (4): 738-748
4. Gnatenko DV, Dunn JJ, McCorkle SR, Weissmann D, Perrotta PL, Bahou WF. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 2003; 101 (6): 2285-2293
5. Schedel A, Rolf N. Genome-wide platelet RNA profiling in clinical samples. Methods Mol Biol 2009; 496: 273-283
6. Rowley JW, Oler AJ, Tolley ND, Hunter BN, Low EN, Nix DA, Yost CC, Zimmerman GA, Weyrich AS. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 2011; 118 (14): e101-e111
7. Bray PF, McKenzie SE, Edelstein LC, Nagalla S, Delgrosso K, Ertel A, Kupper J, Jing Y, Londin E, Loher P, et al. The complex transcriptional landscape of the anucleate human platelet. BMC Genomics 2013; 14: 1
8. Londin ER, Hatzimichael E, Loher P, Edelstein L, Shaw C, Delgrosso K, Fortina P, Bray PF, McKenzie SE, Rigoutsos I. The human platelet: Strong transcriptome correlations among individuals associate weakly with the platelet proteome. Biol Direct 2014; 9: 3
9. Kissopoulou A, Jonasson J, Lindahl TL, Osman A. Next generation sequencing analysis of human platelet PolyA+ mRNAs and rRNA-depleted total RNA. PLoS One 2013; 8 (12): e81809
10. Schubert S, Weyrich AS, Rowley JW. A tour through the transcriptional landscape of platelets. Blood 2014; 124 (4): 493-502
11. Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007; 357 (24): 2482-2494
12. Kottke-Marchant K. Importance of platelets and platelet response in acute coronary syndromes. Cleve Clin J Med 2009; 76: S2-S7
13. Harrison P, Mackie I, Mathur A, Robinson MS, Hong Y, Erusalimsky JD, Machin SJ, Martin JF. Platelet hyper-function in acute coronary syndromes. Blood Coagul Fibrinolysis 2005; 16 (8): 557-562
14. Shields DC, Fitzgerald AP, O'Neill PA, Muckian C, Kenny D, Moran B, Cannon CP, Byrne CE, Fitzgerald DJ. The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists. Pharmacogenomics J 2002; 2 (3): 182-190
15. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Katus HA, Lindahl B, Morrow DA, Clemmensen PM, et al. Third universal definition of myocardial infarction. Circulation 2012; 126 (16): 2020-2035
16. McManus DD, Gore J, Yarzebski J, Spencer F, Lessard D, Goldberg RJ. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am J Med 2011; 124 (1): 40-47
17. Bonello L, Tantry US, Marcucci R, Blindt R, Angiolillo DJ, Becker R, Bhatt DL, Cattaneo M, Collet JP, Cuisset T, et al. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 2010; 56 (12): 919-933
18. Aydinalp A, Atar I, Gulmez O, Atar A, Acikel S, Bozbas H, Ozgul A, Ertan C, Ozin B, Muderrisoglu H. The clinical significance of aspirin resistance in patients with chest pain. Clin Cardiol 2010; 33 (3): E1-E7
19. Bonello L, Berbis J, Laine M, Armero S, Bessereau J, Jacquin L, Bonello C, Camillieri E, Barragan P, Dignat-George F, et al. Biological efficacy of a 600 mg loading dose of clopidogrel in ST-elevation myocardial infarction. Thromb Haemost 2012; 108 (1): 101-106
20. Borna C, Lazarowski E, van HC, Ohlin H, Erlinge D. Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels. Thromb J 2005; 3: 10
21. Silbiger VN, Luchessi AD, Hirata RD, Lima-Neto LG, Cavichioli D, Carracedo A, Brion M, Dopazo J, Garcia-Garcia F, dos Santos ES, et al. Novel genes detected by transcriptional profiling from whole-blood cells in patients with early onset of acute coronary syndrome. Clin Chim Acta 2013; 421: 184-190
22. Vausort M, Wagner DR, Devaux Y. Long noncoding RNAs in patients with acute myocardial infarction. Circ Res 2014; 115 (7): 668-677
23. Healy AM, Pickard MD, Pradhan AD, Wang Y, Chen Z, Croce K, Sakuma M, Shi C, Zago AC, Garasic J, et al. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation 2006; 113 (19): 2278-2284
24. Freedman JE, Larson MG, Tanriverdi K, O'Donnell CJ, Morin K, Hakanson AS, Vasan RS, Johnson AD, Iafrati MD, Benjamin EJ. Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart study. Circulation 2010; 122 (2): 119-129
25. Freedman JE, Farhat JH, Loscalzo J, Keaney Jr JF. Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 1996; 94 (10): 2434-2440
26. Wang J, Duncan D, Shi Z, Zhang B. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): Update 2013. Nucleic Acids Res 2013; 41 (Web Server issue): W77-W83
27. McCarthy DJ, Chen Y, Smyth GK. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res 2012; 40 (10): 4288-4297
28. SEQC-MAQC-III Consortium. A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium. Nat Biotechnol 2014; 32 (9): 903-914
29. Simon LM, Edelstein LC, Nagalla S, Woodley AB, Chen ES, Kong X, Ma L, Fortina P, Kunapuli S, Holinstat M, et al. Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. Blood 2014; 123 (16): e37-e45
30. Raghavachari N, Xu X, Harris A, Villagra J, Logun C, Barb J, Solomon MA, Suffredini AF, Danner RL, Kato G, et al. Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease. Circulation 2007; 115 (12): 1551-1562
31. Ple H, Landry P, Benham A, Coarfa C, Gunaratne PH, Provost P. The repertoire and features of human platelet microRNAs. PLoS One 2012; 7 (12): e50746
32. Willeit P, Zampetaki A, Dudek K, Kaudewitz D, King A, Kirkby NS, Crosby-Nwaobi R, Prokopi M, Drozdov I, Langley SR, et al. Circulating microRNAs as novel biomarkers for platelet activation. Circ Res 2013; 112 (4): 595-600
33. Ishii N, Ozaki K, Sato H, Mizuno H, Saito S, Takahashi A, Miyamoto Y, Ikegawa S, Kamatani N, Hori M, et al. Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J Hum Genet 2006; 51 (12): 1087-1099
34. Crotti L, Celano G, Dagradi F, Schwartz PJ. Congenital long QT syndrome. Orphanet J Rare Dis 2008; 3: 18
35. Lordier L, Chang Y, Jalil A, Aurade F, Garcon L, Lecluse Y, Larbret F, Kawashima T, Kitamura T, Larghero J, et al. Aurora B is dispensable for megakaryocyte polyploidization, but contributes to the endomitotic process. Blood 2010; 116 (13): 2345-2355
36. Nguyen HG, Yu G, Makitalo M, Yang D, Xie HX, Jones MR, Ravid K. Conditional overexpression of transgenes in megakaryocytes and platelets in vivo. Blood 2005; 106 (5): 1559-1564
37. Meisinger C, Prokisch H, Gieger C, Soranzo N, Mehta D, Rosskopf D, Lichtner P, Klopp N, Stephens J, Watkins NA, et al. A genome-wide association study identifies three loci associated with mean platelet volume. Am J Hum Genet 2009; 84 (1): 66-71
38. Johnson AD, Yanek LR, Chen MH, Faraday N, Larson MG, Tofler G, Lin SJ, Kraja AT, Province MA, Yang Q, et al. Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat Genet 2010; 42 (7): 608-613
39. Stankiewicz MJ, Crispino JD. ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells. Blood 2009; 113 (14): 3337-3347
40. Marcucci R, Valente S, Gori AM, Chiostri M, Paniccia R, Giusti B, Cau V, Lazzeri C, Gensini GF, Abbate R. Global platelet hyperreactivity and elevated C-reactive protein levels predict long term mortality in STEMI patients. Thromb Res 2014; 134 (4): 884-888
41. Scalone G, Coviello I, Barone L, Battipaglia I, Aurigemma C, Careri G, Pinnacchio G, Tarzia P, Lanza GA, Crea F. Evidence of increased platelet reactivity in the first six months after acute ST segment elevation myocardial infarction. Thromb Res 2011; 128 (2): 174-178
42. Alexopoulos D, Xanthopoulou I, Tsigkas G, Damelou A, Theodoropoulos KC, Makris G, Gizas V, Kassimis G, Davlouros P, Hahalis G. Intrinsic platelet reactivity and thrombus burden in patients with ST-elevation myocardial infarction. Thromb Res 2013; 131 (4): 333-337
43. Arbelaez LF, Bergmann U, Tuuttila A, Shanbhag VP, Stigbrand T. Interaction of matrix metalloproteinases-2 and -9 with pregnancy zone protein and alpha2-macroglobulin. Arch Biochem Biophys 1997; 347 (1): 62-68
44. Stephens G, Yan Y, Jandrot-Perrus M, Villeval JL, Clemetson KJ, Phillips DR. Platelet activation induces metalloproteinase-dependent GP VI cleavage to down-regulate platelet reactivity to collagen. Blood 2005; 105 (1): 186-191
45. Chang CH, Chung CH, Kuo HL, Hsu CC, Huang TF. The highly specific platelet glycoprotein (GP) VI agonist trowaglerix impaired collagen-induced platelet aggregation ex vivo through matrix metalloproteinase-dependent GPVI shedding. J Thromb Haemost 2008; 6 (4): 669-676
46. Momi S, Falcinelli E, Giannini S, Ruggeri L, Cecchetti L, Corazzi T, Libert C, Gresele P. Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. J Exp Med 2009; 206 (11): 2365-2379
47. Moyes AJ, Khambata RS, Villar I, Bubb KJ, Baliga RS, Lumsden NG, Xiao F, Gane PJ, Rebstock AS, Worthington RJ, et al. Endothelial C-type natriuretic peptide maintains vascular homeostasis. J Clin Invest 2014; 124 (9): 4039-4051
48. Goodall AH, Burns P, Salles I, Macaulay IC, Jones CI, Ardissino D, de BB, Bray SL, Deckmyn H, Dudbridge F, et al. Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function. Blood 2010; 116 (22): 4646-4656
49. Johnson AD. The genetics of common variation affecting platelet development, function and pharmaceutical targeting. J Thromb Haemost 2011; 9 (Suppl 1): 246-257
50. Morange PE, Bezemer I, Saut N, Bare L, Burgos G, Brocheton J, Durand H, Biron-Andreani C, Schved JF, Pernod G, et al. A follow-up study of a genome-wide association scan identifies a susceptibility locus for venous thrombosis on chromosome 6p24.1. Am J Hum Genet 2010; 86 (4): 592-595
51. Heijnen HF, Oorschot V, Sixma JJ, Slot JW, James DE. Thrombin stimulates glucose transport in human platelets via the translocation of the glucose transporter GLUT-3 from alpha-granules to the cell surface. J Cell Biol 1997; 138 (2): 323-330
52. Alshahrani MM, Yang E, Yip J, Ghanem SS, Abdallah SL, deAngelis AM, O'Malley CJ, Moheimani F, Najjar SM, Jackson DE. CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo. Blood 2014; 124 (15): 2431-2441
53. Wong C, Liu Y, Yip J, Chand R, Wee JL, Oates L, Nieswandt B, Reheman A, Ni H, Beauchemin N, et al. CEACAM1 negatively regulates platelet-collagen interactions and thrombus growth in vitro and in vivo. Blood 2009; 113 (8): 1818-1828
54. Odin P, Asplund M, Busch C, Obrink B. Immunohistochemical localization of cellCAM 105 in rat tissues: Appearance in epithelia, platelets, and granulocytes. J Histochem Cytochem 1988; 36 (7): 729-739
55. Marjoram RJ, Li Z, He L, Tollefsen DM, Kunicki TJ, Dickeson SK, Santoro SA, Zutter MM. Alpha2beta1 integrin, GPVI receptor, and common FcRgamma chain on mouse platelets mediate distinct responses to collagen in models of thrombosis. PLoS One 2014; 9 (11): e114035
56. Holtkotter O, Nieswandt B, Smyth N, Muller W, Hafner M, Schulte V, Krieg T, Eckes B. Integrin alpha 2-deficient mice develop normally, are fertile, but display partially defective platelet interaction with collagen. J Biol Chem 2002; 277 (13): 10789-10794
57. Fang L, Yan Y, Komuves LG, Yonkovich S, Sullivan CM, Stringer B, Galbraith S, Lokker NA, Hwang SS, Nurden P, et al. PDGF C is a selective alpha platelet-derived growth factor receptor agonist that is highly expressed in platelet alpha granules and vascular smooth muscle. Arterioscler Thromb Vasc Biol 2004; 24 (4): 787-792
58. Gilbertson DG, Duff ME, West JW, Kelly JD, Sheppard PO, Hofstrand PD, Gao Z, Shoemaker K, Bukowski TR, Moore M, et al. Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor. J Biol Chem 2001; 276 (29): 27406-27414
59. Rosenkranz S, Kazlauskas A. Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes. Growth Factors 1999; 16 (3): 201-216
60. Pleines I, Hagedorn I, Gupta S, May F, Chakarova L, van HJ, Offermanns S, Krohne G, Kleinschnitz C, Brakebusch C, et al. Megakaryocyte-specific RhoA deficiency causes macrothrombocytopenia and defective platelet activation in hemostasis and thrombosis. Blood 2012; 119 (4): 1054-1063